{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T03:32:50Z","timestamp":1772076770176,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"DOI":"10.1186\/s12911-025-02886-z","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T18:24:36Z","timestamp":1738002276000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Insights into prescribing patterns for antidepressants: an evidence-based analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Hua","family":"Min","sequence":"first","affiliation":[]},{"given":"Farrokh","family":"Alemi","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"issue":"5","key":"2886_CR1","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cellsig.2004.12.007","volume":"17","author":"C Taylor","year":"2005","unstructured":"Taylor C, Fricker AD, Devi LA, Gomes I. Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways. Cell Signal. 2005;17(5):549\u201357. https:\/\/doi.org\/10.1016\/j.cellsig.2004.12.007.","journal-title":"Cell Signal"},{"issue":"Suppl 4","key":"2886_CR2","first-page":"5","volume":"59","author":"SM Stahl","year":"1998","unstructured":"Stahl SM. Basic psychopharmacology of antidepressants, part 1: antidepressants have seven distinct mechanisms of action. J Clin Psychiatry. 1998;59(Suppl 4):5\u201314.","journal-title":"J Clin Psychiatry"},{"key":"2886_CR3","first-page":"4","volume":"52 Suppl","author":"GD Tollefson","year":"1991","unstructured":"Tollefson GD. Antidepressant treatment and side effect considerations. J Clin Psychiatry. 1991;52 Suppl:4\u201313.","journal-title":"J Clin Psychiatry"},{"issue":"9665","key":"2886_CR4","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","volume":"373","author":"A Cipriani","year":"2009","unstructured":"Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009;373(9665):746\u201358. https:\/\/doi.org\/10.1016\/S0140-6736(09)60046-5.","journal-title":"Lancet"},{"issue":"1","key":"2886_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1747-5341-3-14","volume":"3","author":"JP Ioannidis","year":"2008","unstructured":"Ioannidis JP. Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials? Philos Ethics Humanit Med. 2008;3(1):14. https:\/\/doi.org\/10.1186\/1747-5341-3-14.","journal-title":"Philos Ethics Humanit Med"},{"issue":"3","key":"2886_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMsa065779","volume":"358","author":"EH Turner","year":"2008","unstructured":"Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358(3):252\u201360. https:\/\/doi.org\/10.1056\/NEJMsa065779.","journal-title":"N Engl J Med"},{"key":"2886_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.comppsych.2014.09.007","volume":"56","author":"M Zimmerman","year":"2015","unstructured":"Zimmerman M, Ellison W, Young D, Chelminski I, Dalrymple K. How many different ways do patients meet the diagnostic criteria for major depressive disorder? Compr Psychiatry. 2015;56:29\u201334. https:\/\/doi.org\/10.1016\/j.comppsych.2014.09.007.","journal-title":"Compr Psychiatry"},{"issue":"1","key":"2886_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s40271-019-00383-w","volume":"13","author":"M Hopwood","year":"2020","unstructured":"Hopwood M. The Shared decision-making process in the Pharmacological Management of Depression. Patient - Patient-Centered Outcomes Res. 2020;13(1):23\u201330. https:\/\/doi.org\/10.1007\/s40271-019-00383-w.","journal-title":"Patient - Patient-Centered Outcomes Res"},{"key":"2886_CR9","unstructured":"Clinical Practice Guideline for the Treatment of Depression. Accessed October 24. 2024. https:\/\/www.apa.org\/depression-guideline"},{"issue":"4 Suppl","key":"2886_CR10","first-page":"1","volume":"157","author":"Practice guideline for the","year":"2000","unstructured":"Practice guideline for the. Treatment of patients with major depressive disorder (revision). American Psychiatric Association. Am J Psychiatry. 2000;157(4 Suppl):1\u201345.","journal-title":"Am J Psychiatry"},{"key":"2886_CR11","unstructured":"Management of Major Depressive Disorder (MDD). Published online 2022. Accessed October 24. 2024. https:\/\/www.healthquality.va.gov\/guidelines\/MH\/mdd\/"},{"key":"2886_CR12","unstructured":"Depression in adults: treatment and management. Accessed October 24. 2024. https:\/\/www.nice.org.uk\/guidance\/ng222"},{"key":"2886_CR13","doi-asserted-by":"publisher","unstructured":"Lam RW, Kennedy SH, Adams C, \u2019anxi\u00e9t\u00e9 (CANMAT). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: R\u00e9seau canadien pour les traitements de l\u2019humeur et de l 2023: Mise \u00e0 jour des lignes directrices cliniques pour la prise en charge du trouble d\u00e9pressif majeur chez les adultes. Can J Psychiatry. Published online May 6, 2024:07067437241245384. https:\/\/doi.org\/10.1177\/07067437241245384","DOI":"10.1177\/07067437241245384"},{"issue":"4","key":"2886_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/0272989X231166009","volume":"43","author":"A Stallman","year":"2023","unstructured":"Stallman A, Sheeran N, Boschen M. A qualitative exploration of General practitioners\u2019 treatment decision-making for depressive symptoms. Med Decis Mak. 2023;43(4):498\u2013507. https:\/\/doi.org\/10.1177\/0272989X231166009.","journal-title":"Med Decis Mak"},{"issue":"1","key":"2886_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/ijms19010233","volume":"19","author":"M Jha","year":"2018","unstructured":"Jha M, Trivedi M. Personalized antidepressant selection and pathway to Novel treatments: clinical utility of targeting inflammation. Int J Mol Sci. 2018;19(1):233. https:\/\/doi.org\/10.3390\/ijms19010233.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2886_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/acps.13640","volume":"149","author":"A Jorgensen","year":"2024","unstructured":"Jorgensen A, Larsen EN, Sloth MMB, Kessing LV, Osler M. Prescription patterns in unipolar depression: a nationwide Danish register-based study of 113,175 individuals followed for 10 years. Acta Psychiatr Scand. 2024;149(2):88\u201397. https:\/\/doi.org\/10.1111\/acps.13640.","journal-title":"Acta Psychiatr Scand"},{"issue":"12","key":"2886_CR17","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.2174\/1570159X20666220222142310","volume":"20","author":"B Dell\u2019Osso","year":"2022","unstructured":"Dell\u2019Osso B, Di Nicola M, Cipelli R, et al. Antidepressant prescription for major depressive disorder: results froma Population-based study in Italy. Curr Neuropharmacol. 2022;20(12):2381\u201392. https:\/\/doi.org\/10.2174\/1570159X20666220222142310.","journal-title":"Curr Neuropharmacol"},{"issue":"10","key":"2886_CR18","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1177\/00048674231158267","volume":"57","author":"MJ Lennon","year":"2023","unstructured":"Lennon MJ, Harmer C. Machine learning prediction will be part of future treatment of depression. Aust N Z J Psychiatry. 2023;57(10):1316\u201323. https:\/\/doi.org\/10.1177\/00048674231158267.","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"2886_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12991-023-00483-w","volume":"23","author":"Y Hao","year":"2024","unstructured":"Hao Y, Zhang J, Yu J, et al. Predicting quetiapine dose in patients with depression using machine learning techniques based on real-world evidence. Ann Gen Psychiatry. 2024;23(1):5. https:\/\/doi.org\/10.1186\/s12991-023-00483-w.","journal-title":"Ann Gen Psychiatry"},{"issue":"1","key":"2886_CR20","first-page":"17","volume":"24","author":"T Jambor","year":"2022","unstructured":"Jambor T, Juhasz G, Eszlari N. Towards personalised antidepressive medicine based on big data: an up-to-date review on robust factors affecting treatment response. Neuropsychopharmacol Hung Magy Pszichofarmakologiai Egyesulet Lapja off J Hung Assoc Psychopharmacol. 2022;24(1):17\u201328.","journal-title":"Neuropsychopharmacol Hung Magy Pszichofarmakologiai Egyesulet Lapja off J Hung Assoc Psychopharmacol"},{"issue":"4","key":"2886_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/0272989X8800800404","volume":"8","author":"RS Wigton","year":"1988","unstructured":"Wigton RS. Use of Linear models to Analyze Physicians\u2019 decisions. Med Decis Mak. 1988;8(4):241\u201352. https:\/\/doi.org\/10.1177\/0272989X8800800404.","journal-title":"Med Decis Mak"},{"issue":"1","key":"2886_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12911-023-02410-1","volume":"24","author":"M Gunlicks-Stoessel","year":"2024","unstructured":"Gunlicks-Stoessel M, Liu Y, Parkhill C, et al. Adolescent, parent, and provider attitudes toward a machine learning based clinical decision support system for selecting treatment for youth depression. BMC Med Inf Decis Mak. 2024;24(1):4. https:\/\/doi.org\/10.1186\/s12911-023-02410-1.","journal-title":"BMC Med Inf Decis Mak"},{"key":"2886_CR23","doi-asserted-by":"publisher","unstructured":"Alemi F, Min H, Yousefi M, et al. Procedure for Organizing a Post-FDA-approval evaluation of antidepressants. Cureus Published Online Oct. 2022;3. https:\/\/doi.org\/10.7759\/cureus.29884.","DOI":"10.7759\/cureus.29884"},{"issue":"1","key":"2886_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12888-021-03133-1","volume":"21","author":"F Alemi","year":"2021","unstructured":"Alemi F, Aljuaid M, Durbha N, et al. A surrogate measure for patient reported symptom remission in administrative data. BMC Psychiatry. 2021;21(1):121. https:\/\/doi.org\/10.1186\/s12888-021-03133-1.","journal-title":"BMC Psychiatry"},{"key":"2886_CR25","doi-asserted-by":"publisher","first-page":"101171","DOI":"10.1016\/j.eclinm.2021.101171","volume":"41","author":"F Alemi","year":"2021","unstructured":"Alemi F, Min H, Yousefi M, et al. Effectiveness of common antidepressants: a post market release study. eClinicalMedicine. 2021;41:101171. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101171.","journal-title":"eClinicalMedicine"},{"issue":"2","key":"2886_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1467-9868.2011.01004.x","volume":"74","author":"R Tibshirani","year":"2012","unstructured":"Tibshirani R, Bien J, Friedman J, et al. Strong rules for discarding predictors in Lasso-Type problems. J R Stat Soc Ser B Stat Methodol. 2012;74(2):245\u201366. https:\/\/doi.org\/10.1111\/j.1467-9868.2011.01004.x.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"issue":"1","key":"2886_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.09.004","volume":"78","author":"M Torrens","year":"2005","unstructured":"Torrens M, Fonseca F, Mateu G, Farr\u00e9 M. Efficacy of antidepressants in substance use disorders with and without comorbid depression. Drug Alcohol Depend. 2005;78(1):1\u201322. https:\/\/doi.org\/10.1016\/j.drugalcdep.2004.09.004.","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"2886_CR28","first-page":"609","volume":"100","author":"SS Selph","year":"2019","unstructured":"Selph SS, McDonagh MS. Depression in Children and adolescents: evaluation and treatment. Am Fam Physician. 2019;100(10):609\u201317.","journal-title":"Am Fam Physician"},{"issue":"3","key":"2886_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s41999-023-00790-1","volume":"14","author":"A Coin","year":"2023","unstructured":"Coin A, Noale M, Gareri P, et al. Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study. Eur Geriatr Med. 2023;14(3):465\u201376. https:\/\/doi.org\/10.1007\/s41999-023-00790-1.","journal-title":"Eur Geriatr Med"},{"issue":"5","key":"2886_CR30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.genhosppsych.2012.03.014","volume":"34","author":"F Uguz","year":"2012","unstructured":"Uguz F, Sahingoz M, Kose SA, et al. Antidepressants and menstruation disorders in women: a cross-sectional study in three centers. Gen Hosp Psychiatry. 2012;34(5):529\u201333. https:\/\/doi.org\/10.1016\/j.genhosppsych.2012.03.014.","journal-title":"Gen Hosp Psychiatry"},{"key":"2886_CR31","doi-asserted-by":"publisher","unstructured":"Min H, Alemi F, Wojtusiak J. Selecting antidepressants based on medical history and stress mechanism. Cureus Published Online April. 2023;4. https:\/\/doi.org\/10.7759\/cureus.37117.","DOI":"10.7759\/cureus.37117"},{"key":"2886_CR32","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.2147\/NDT.S434130","volume":"19","author":"A Fagiolini","year":"2023","unstructured":"Fagiolini A, Gonz\u00e1lez Pinto A, Miskowiak K, Morgado P, Young A, Vieta E. Trazodone in the management of Major Depression among Elderly patients with dementia: a narrative review and clinical insights. Neuropsychiatr Dis Treat. 2023;19:2817\u201331. https:\/\/doi.org\/10.2147\/NDT.S434130.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"2886_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4140\/TCP.n.2014.124","volume":"29","author":"O Hilas","year":"2014","unstructured":"Hilas O, Avena-Woods C. Potential role of Mirtazapine in underweight older adults. Consult Pharm. 2014;29(2):124\u201330. https:\/\/doi.org\/10.4140\/TCP.n.2014.124.","journal-title":"Consult Pharm"},{"issue":"11","key":"2886_CR34","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s40262-023-01294-8","volume":"62","author":"EA Poweleit","year":"2023","unstructured":"Poweleit EA, Taylor ZL, Mizuno T, et al. Escitalopram and Sertraline Population Pharmacokinetic Analysis in Pediatric patients. Clin Pharmacokinet. 2023;62(11):1621\u201337. https:\/\/doi.org\/10.1007\/s40262-023-01294-8.","journal-title":"Clin Pharmacokinet"},{"key":"2886_CR35","doi-asserted-by":"publisher","unstructured":"Hetrick SE, McKenzie JE, Bailey AP, et al. New generation antidepressants for depression in children and adolescents: a network meta-analysis. ed Cochrane Database Syst Rev. 2021;2021(5). https:\/\/doi.org\/10.1002\/14651858.CD013674.pub2. Cochrane Common Mental Disorders Group.","DOI":"10.1002\/14651858.CD013674.pub2"},{"issue":"3","key":"2886_CR36","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/GRF.0b013e3181b52e20","volume":"52","author":"JL Payne","year":"2009","unstructured":"Payne JL, Meltzer-Brody S. Antidepressant use during pregnancy: current controversies and treatment strategies. Clin Obstet Gynecol. 2009;52(3):469\u201382. https:\/\/doi.org\/10.1097\/GRF.0b013e3181b52e20.","journal-title":"Clin Obstet Gynecol"},{"issue":"2","key":"2886_CR37","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10549-015-3465-5","volume":"152","author":"R Ramaswami","year":"2015","unstructured":"Ramaswami R, Villarreal MD, Pitta DM, Carpenter JS, Stebbing J, Kalesan B. Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2015;152(2):231\u20137. https:\/\/doi.org\/10.1007\/s10549-015-3465-5.","journal-title":"Breast Cancer Res Treat"},{"key":"2886_CR38","doi-asserted-by":"publisher","unstructured":"Carey TL. Use of antidepressants in patients with co-occurring Depression and Substance Use disorders. In: Macaluso M, Preskorn SH, editors. Antidepressants. Handbook of Experimental Pharmacology. Springer International Publishing; 2018; pp. 250:359\u201370. https:\/\/doi.org\/10.1007\/164_2018_162.","DOI":"10.1007\/164_2018_162"},{"issue":"6","key":"2886_CR39","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1055\/s-0029-1220929","volume":"88","author":"B Kusma","year":"2009","unstructured":"Kusma B, Mache S, Deissenrieder F, Quarcoo D, Welte T, Groneberg D. Current and future medical drugs for smoking cessation. Laryngorhinootologie. 2009;88(6):410\u20139. https:\/\/doi.org\/10.1055\/s-0029-1220929. quiz 420-422.","journal-title":"Laryngorhinootologie"},{"issue":"03","key":"2886_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1055\/s-2007-1017162","volume":"19","author":"K T\u00e4schner","year":"1986","unstructured":"T\u00e4schner K. A controlled comparison of Clonidine and Doxepin in the treatment of the Opiate Withdrawal Syndrome. Pharmacopsychiatry. 1986;19(03):91\u20135. https:\/\/doi.org\/10.1055\/s-2007-1017162.","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"2886_CR41","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s12888-021-03490-x","volume":"21","author":"CF Vos","year":"2021","unstructured":"Vos CF, Aarnoutse RE, Op De Coul MJM, et al. Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands. BMC Psychiatry. 2021;21(1):481. https:\/\/doi.org\/10.1186\/s12888-021-03490-x.","journal-title":"BMC Psychiatry"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-02886-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-025-02886-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-02886-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T18:24:39Z","timestamp":1738002279000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-025-02886-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2886"],"URL":"https:\/\/doi.org\/10.1186\/s12911-025-02886-z","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent was obtained or waived by all participants in this study. George Mason University Institutional Review Board issued approval NA. Ethics approval was granted by the George Mason University Institutional Review Board. Patients and\/or the public were not involved in the design, conduct, reporting, nor dissemination plans of this research.:","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"In this study, informed consent was waived by the George Mason University Institutional Review Board because the research involves a deidentified secondary analysis. The need for consent to participate was waived by the George Mason University Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent waiver statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}